[Federal Register: August 27, 2007 (Volume 72, Number 165)]
[Notices]               
[Page 49018]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr27au07-66]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated April 17, 2007, and published in the Federal 
Register on April 30, 2007, (72 FR 21298), Amri Rensselaer, Inc. 
(formerly: Organichem Corporation), 33 Riverside Avenue, Rensselaer, 
New York 12144, made application by letter to the Drug Enforcement 
Administration (DEA) to be registered as a bulk manufacturer of 
Oxymorphone (9652), a basic class of controlled substance listed in 
schedule II.
    The company plans on manufacturing the listed controlled substance 
in bulk for sale to its customer.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Amri Rensselaer, Inc. to manufacture the listed basic class of 
controlled substance is consistent with the public interest at this 
time. DEA has investigated Amri Rensselaer, Inc. to ensure that the 
company's registration is consistent with the public interest. The 
investigation has included inspection and testing of the company's 
physical security systems, verification of the company's compliance 
with state and local laws, and a review of the company's background and 
history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 
21 CFR 1301.33, the above named company is granted registration as a 
bulk manufacturer of the basic class of controlled substance listed.

    Dated: August 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. E7-16856 Filed 8-24-07; 8:45 am]

BILLING CODE 4410-09-P